Intersect ENT (XENT) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts XENT Hot Sheet
Join SI Premium – FREE
Intersect ENT (NASDAQ: XENT) reported Q4 EPS of ($0.17), $0.03 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $24.2 million versus the consensus estimate of $23.47 million.
For earnings history and earnings-related data on Intersect ENT (XENT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
- Nuvve Holdin (NVVE) Misses Q2 EPS by 1445c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
